Sotylize (Sotalol HCl) Patent Expiration, LOE Window & CMS Spending

Sotylize (Sotalol HCl) by Azurity: FDA Orange Book LOE 2035-08-31, 9 AB generics, $2.5M 2024 CMS Part D & Medicaid spend, and 6 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAzurity
FDA Application & PathwayN205108 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2035-08-31
Orange Book Patents (*PED Extensions)5 patents (0 *PED)
Active AB-Rated Generic Competitors9
2024 CMS Total Public Spend$2.5M
2024 Medicare Part D Spend$52K
2024 Medicaid Spend$2.5M
Reported Wholesale Price Change (CA SB 17)6 WAC filings (max 24.3% 2-yr change)